# Pain management and patient education interventions to increase physical activity in people with intermittent claudication (PrEPAID): a feasibility randomised controlled trial in the UK

**Authors:** Chris Seenan, Ukachukwu Abaraogu, Philippa Margaret Dall, Lesley Gilmour, Garry Tew, Wesley Stuart, Andrew Elders, Julie Brittenden

PMC · DOI: 10.1136/bmjopen-2025-105563 · BMJ Open · 2025-07-22

## TL;DR

This study tested if using TENS and patient education can help people with leg pain due to poor blood flow to be more physically active.

## Contribution

The study evaluated the feasibility of combining TENS and education for increasing physical activity in intermittent claudication.

## Key findings

- The trial was feasible with high retention and adherence rates.
- Participants had mixed experiences with TENS due to device size and wires.
- 40% of potential participants were excluded due to research fidelity issues.

## Abstract

To explore the feasibility and acceptability of pain management (transcutaneous electrical nerve stimulation (TENS)) and patient education (PE) to increase physical activity in people with peripheral arterial disease and intermittent claudication (IC).

Feasibility randomised controlled trial with embedded process evaluation.

One secondary care UK vascular centre.

56 community-dwelling adults with a history of stable IC and ankle-brachial pressure index ≤0.9 were recruited via claudication clinics.

Participants randomised to 6 weeks of: TENS+PE, TENS, Placebo TENS+PE or Placebo TENS. PE was a 3-hour workshop plus three follow-up phone calls. The TENS machine was worn during walking (TENS: 120 Hz, 200 μs, intensity ‘strong but comfortable’; Placebo TENS: intensity below sensation threshold).

Primary feasibility outcomes included rates of recruitment, retention and adherence. Acceptability of the intervention and trial procedures was explored with semistructured interviews. Measures of walking capacity, walking behaviour, quality of life, disease perception and pain were recorded at baseline, end of intervention (6 weeks) and follow-up (3 months).

56 participants were randomised from 95 who completed baseline screening. Of the 39 excluded, 97% (38/39) had >20% variability in absolute claudication distance. All participants received their allocated intervention. Outcome completion was 91% at 6 weeks and 80% at 3 months. Attendance at group education was 96% with 63% taking follow-up phone calls. Compliance with TENS was 70% according to participant-completed logs. Interviewed participants (n=9) were generally positive about the acceptability of the interventions and trial procedures; however, experience of TENS use was mixed. Some participants were dissatisfied with the size of the device and electrode wires.

The PrEPAID (Pain management and Patient Education for Physical Activity in Intermittent claudication) trial was feasible to run; however, 40% of potential participants were excluded at screening due to issues of research fidelity rather than participant suitability or willingness to participate. A future definitive trial should consider a revised primary outcome measure and smaller wireless TENS machines.

ClinicalTrials.gov, NCT03204825. Registered on 2 July 2017.

Chief Scientist Office, Scottish Government. Translational grant award (TCS/16/55).

## Linked entities

- **Diseases:** peripheral arterial disease (MONDO:0005386)

## Full-text entities

- **Diseases:** peripheral arterial disease (MESH:D058729), Pain (MESH:D010146), IC (MESH:D007383)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12306470/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12306470/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12306470/full.md

---
Source: https://tomesphere.com/paper/PMC12306470